The Oral Proteasome Inhibitor Ixazomib in Combination with Melphalan-Prednisone (MP) for Patients with Newly Diagnosed Multiple Myeloma (NDMM): Phase 1/2 Dose-Escalation Study (NCT01335685)
San Miguel, Jesus, Echeveste Gutierrez, Maria Asunción, Špicka, Ivan, Mateos, María-Victoria, Song, Kevin, Craig, Michael, Bladé, Joan, Hájek, Roman, Chen, Christine, Gupta, Neeraj, Byrne, Catriona, LVolume:
17
Language:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2017.07.153
Date:
September, 2017
File:
PDF, 93 KB
english, 2017